PROVIDER PROFILE · NPI 1881876266

Celeste Cheryll QuianzonMD

EndocrinologySkowhegan, MEI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$3K

Peer benchmark

Total Medicare services vs. 22 Endocrinology providers in ME — bottom quintile (cohort median 280).

PRESCRIBING · PART D · 2024

Total Rx claims

384

Beneficiaries

—

Total drug cost

$88K

Distinct drugs

Brand share

37.5%

Top prescribed drugs

Levothyroxine Sodium131 claims

Methimazole71 claims

Dulaglutide33 claims

Levothyroxine Sodium28 claims

Empagliflozin25 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Celeste Cheryll Quianzon's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
REDINGTON-FAIRVIEW GENERAL HOSPITAL	264	1,815
EASTERN MAINE HEALTHCARE SYSTEMS INLAND HOSPITAL	57	344
Cathal Kavanagh Family Practice · Skowhegan, ME	27	143
Oto Prokop Internal Medicine · Skowhegan, ME	22	79
SEBASTICOOK VALLEY HEALTH	19	98
Nordx Clinical Laboratory · Scarborough, ME	16	54

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history